DK359387A - Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling - Google Patents

Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling

Info

Publication number
DK359387A
DK359387A DK359387A DK359387A DK359387A DK 359387 A DK359387 A DK 359387A DK 359387 A DK359387 A DK 359387A DK 359387 A DK359387 A DK 359387A DK 359387 A DK359387 A DK 359387A
Authority
DK
Denmark
Prior art keywords
solutions
preparation
oxazaphosphorines
procedure
improved stability
Prior art date
Application number
DK359387A
Other languages
English (en)
Other versions
DK168322B1 (da
DK359387D0 (da
Inventor
Dieter Sauerbier
Klaus Molge
Werner Weigert
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of DK359387D0 publication Critical patent/DK359387D0/da
Publication of DK359387A publication Critical patent/DK359387A/da
Application granted granted Critical
Publication of DK168322B1 publication Critical patent/DK168322B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Paper (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DK359387A 1986-07-11 1987-07-10 Ethanoliske opløsninger af oxazaphosphoriner med forbedret stabilitet DK168322B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3623369 1986-07-11
DE3623369 1986-07-11

Publications (3)

Publication Number Publication Date
DK359387D0 DK359387D0 (da) 1987-07-10
DK359387A true DK359387A (da) 1988-01-12
DK168322B1 DK168322B1 (da) 1994-03-14

Family

ID=6304930

Family Applications (1)

Application Number Title Priority Date Filing Date
DK359387A DK168322B1 (da) 1986-07-11 1987-07-10 Ethanoliske opløsninger af oxazaphosphoriner med forbedret stabilitet

Country Status (16)

Country Link
US (1) US4952575A (da)
EP (1) EP0254902B1 (da)
JP (1) JPS6323888A (da)
KR (1) KR880001282A (da)
AT (1) ATE66609T1 (da)
AU (1) AU598282B2 (da)
CA (1) CA1289886C (da)
DE (2) DE3772482D1 (da)
DK (1) DK168322B1 (da)
ES (1) ES2038623T3 (da)
FI (1) FI86690C (da)
GR (1) GR3002618T3 (da)
IE (1) IE59897B1 (da)
IL (1) IL83141A (da)
PT (1) PT85293B (da)
ZA (1) ZA875059B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
ES2277397T3 (es) * 1997-10-13 2007-07-01 Stada Arzneimittel Ag Formas liquidas de administracion de productos farmaceuticos que contienen oxazafosforina.
US7205404B1 (en) * 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
AUPQ849900A0 (en) * 2000-06-30 2000-07-27 Dbl Australia Pty Ltd. Injectable composition
US6613927B1 (en) 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods
NZ538584A (en) * 2002-09-05 2007-05-31 Bharat Serums & Vaccines Ltd Stable liquid composition of oxazaphosphorine, mesna and etherified beta-cyclodextrin
US7199111B2 (en) * 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations
WO2006030450A2 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
CA2948148C (en) * 2014-05-09 2022-12-06 AuroMedics Pharma LLC Formulations of cyclophosphamide liquid concentrate
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
US10849916B2 (en) 2014-07-11 2020-12-01 Dr. Reddys Laboratories Limited Stable liquid formulations of cyclophosphamide and its impurities
WO2016005962A2 (en) 2014-07-11 2016-01-14 Dr. Reddy’S Laboratories Limited Stable liquid formulations of cyclophosphamide and processes
WO2016132270A1 (en) 2015-02-16 2016-08-25 Leiutis Pharmaceuticals Pvt Ltd Stable ready to use cyclophosphamide liquid formulations
CA3087932A1 (en) 2018-01-09 2019-07-18 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
US20230310468A1 (en) * 2020-08-17 2023-10-05 Sandoz Ag Parenteral pharmaceutical composition comprising cyclophosphamide and a mixture of liquids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3530147A1 (de) * 1985-08-23 1987-02-26 Bayer Ag Verwendung von diazaphosphorinen zur bekaempfung von endoparasiten

Also Published As

Publication number Publication date
GR3002618T3 (en) 1993-01-25
EP0254902A2 (de) 1988-02-03
ES2038623T3 (es) 1993-08-01
JPH0543711B2 (da) 1993-07-02
JPS6323888A (ja) 1988-02-01
PT85293B (pt) 1990-03-30
DE3772482D1 (de) 1991-10-02
FI873064L (fi) 1988-01-12
ATE66609T1 (de) 1991-09-15
FI873064A0 (fi) 1987-07-10
AU7554987A (en) 1988-01-14
EP0254902A3 (en) 1988-08-03
AU598282B2 (en) 1990-06-21
FI86690B (fi) 1992-06-30
KR880001282A (ko) 1988-04-22
IL83141A0 (en) 1987-12-31
PT85293A (de) 1987-08-01
US4952575A (en) 1990-08-28
IE871867L (en) 1988-01-11
IL83141A (en) 1992-11-15
CA1289886C (en) 1991-10-01
EP0254902B1 (de) 1991-08-28
ZA875059B (en) 1988-02-24
DE3722043A1 (de) 1988-01-14
DK168322B1 (da) 1994-03-14
IE59897B1 (en) 1994-04-20
DK359387D0 (da) 1987-07-10
FI86690C (fi) 1992-10-12

Similar Documents

Publication Publication Date Title
DK359387D0 (da) Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling
DK499088D0 (da) 1-oe(2-pyrimidinyl)-aminoalkylaapiperidinderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne derivater
NO172437C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser
NO895002L (no) Enzymhemmende aminosyrederivater.
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
DK640687A (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
DK440987A (da) Thyroninderivater, deres fremstilling og anvendelse
NO871575L (no) Fremgangsmaate for fremstilling av 1,5-benztiazepin-derivater.
ATE139441T1 (de) Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe
NO164352C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive, antivirale, substituerte isoksazolderivater.
ATE70838T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE22284T1 (de) 2-aminomethyl-6-sulfamoylphenolderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
DE3768469D1 (de) N-substituierte, estergruppen enthaltende acrylamide.
SE8302452D0 (sv) Method for treatment of senile dementia
ES2058542T3 (es) Imidas biciclicas puenteadas de 4-(4-(3-benzoisotiazolil)-1-piperazinil)butilo antipsicoticas.
DK148058C (da) Analogifremgangsmaade til fremstilling af thiazolderivater eller syreadditionssalte deraf
DK469381A (da) Piperidinderivater og fremgangsmaade til deres fremstilling
IL78641A0 (en) Preparation of optically active azole derivatives
SE7905862L (sv) Substituerade 4-aryl-2,5-dihydro-furan-2-oner och 4-aryl-1,5-dihydro-2h-pyrrol-2-oner och sett for deras framstellning

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired